Bisphosphonate treatment in primary breast cancer: Results from a randomised comparison of oral pamidronate versus no pamidronate in patients with primary breast cancer

By Kristensen Bent   Ejlertsen Bent   Mouridsen Henning   Jensen Maj-Britt   Andersen Jørn   Bjerregaard Brita   Cold Søren   Edlund Per   Ewertz Marianne   Kamby Claus   Lindman Henrik   Nordenskjold Bo   Bergh Jonas  

Acta Oncologica, Vol. 47, Iss. 4, 2008-01 ,pp. : 740-746

Informa Healthcare

Access to resources Recommend Favorite

Pamidronate Infusions as Single-agent Therapy for Bone Metastases: A Phase II Trial in Patients with Breast Cancer

By Tyrrell C.T.   Bruning P.F.   May-Levin F.   Rose C.   Mauriac L.   Soukop M.   Ford J.M.  

European Journal of Cancer, Vol. 31, Iss. 12, 1995-11 ,pp. : 1976-1980

Elsevier

Access to resources Recommend Favorite

Does Supportive Pamidronate Treatment Prevent or Delay the First Manifestation of Bone Metastases in Breast Cancer Patients?

By van Holten-Verzantvoort A.T.M.   Hermans J.   Beex L.V.A.M.   Blijham G.   Cleton F.J.   van Eck-Smit B.C.F.   Sleeboom H.P.   Papapoulos S.E.  

European Journal of Cancer, Vol. 32, Iss. 3, 1996-03 ,pp. : 450-454

Elsevier

Access to resources Recommend Favorite

Combination of Oral Idarubicin and Prednimustine in Advanced Breast Cancer: a Phase II Study

By Barnadas A.   Mendiola C.   Casado A.   Villar A.   Jimeno J.   Clerigue M.   Rosell R.   Diaz-Rubio E.   Cortes-Funes H.   Garci de Paredes M.  

European Journal of Cancer, Vol. 33, Iss. 2, 1997-02 ,pp. : 312-315

Elsevier

Access to resources Recommend Favorite

Can bone markers guide more effective treatment of bone metastases from breast cancer?

By Clemons Mark   Cole David   Gainford Mary  

Breast Cancer Research and Treatment, Vol. 97, Iss. 1, 2006-05 ,pp. : 81-90

Springer Publishing Company

Access to resources Recommend Favorite